Back to Search
Start Over
Učinci simvastatina i fenofibrata na aktivnost butirilkolinesteraze u mozgu, plazmi i jetri normolipidemičnih i hiperlipidemičnih štakora
- Source :
- Arhiv za higijenu rada i toksikologiju, Volume 70, Issue 1
- Publication Year :
- 2019
- Publisher :
- Institute for Medical Research and Occupational Health, 2019.
-
Abstract
- The study objective was to test the hypothesis that simvastatin and fenofibrate should cause an increase in butyrylcholinesterase (BuChE) activity not only in the plasma and liver but also in the brain of normolipidemic and hyperlipidemic rats. Catalytic enzyme activity was measured using acetylthiocholine (ATCh) and butyrylthiocholine (BTCh) as substrates. Normolipidemic and hyperlipidemic rats were divided in four groups receiving 50 mg/kg of simvastatin a day or 30 mg/kg of fenofibrate a day for three weeks and three control groups receiving saline. Simvastatin and fenofibrate caused an increase in brain BuChE activity in both normo- and hyperlipidemic rats regardless of the substrate. The increase with BTCh as substrate was significant and practically the same in normolipidemic and hyperlipidemic rats after simvastatin treatment (14–17% vs controls). Simvastatin and fenofibrate also increased liver and plasma BuChE activity in both normolipidemic and hyperlipidemic rats regardless of the substrate. In most cases the increase was significant. Considering the important role of BuChE in cholinergic transmission as well as its pharmacological function, it is necessary to continue investigations of the effects of lipid-lowering drugs on BuChE activity.<br />Cilj ispitivanja bio je u normolipidemičnih i hiperlipidemičnih štakora potvrditi pretpostavku da simvastatin (SIMV) I fenofibrat (FENO) ne uzrokuju samo povećanje aktivnosti butirilkolinesteraze (BuChE) u plazmi i jetri nego i povećavaju aktivnosti BuChE u mozgu. Katalitička aktivnost enzima mjerena je upotrebom acetiltiokolina (ATCh) i butiriltiokolina (BTCh) kao supstrata. Normolipidemični i hiperlipidemični štakori raspoređeni su u eksperimentalne skupine, koje su tri tjedna primale SIMV 50 mg/kg na dan ili FENO 30 mg/kg na dan, dok su kontrolne skupine primale fiziološku otopinu. I SIMV i FENO uglavnom su izazvali povećanje aktivnosti BuChE u mozgu obaju sojeva štakora bez obzira na korišteni supstrat. Aktivnosti BuChE mjerene BTCh kao supstratom bile su značajno veće u odnosu na kontrolne vrijednosti u mozgu normolipidemičih štakora nakon primjene SIMV te u mozgu hiperlipidemičnih štakora nakon primjene obaju agensa (14‒17%, p
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Simvastatin
medicine.medical_treatment
Hyperlipidemias
Toxicology
acetylthiocoline
butyrylthiocholine
lipid-lowering drugs
Wistar rats
Zucker rats
Butyrylthiocholine
acetiltiokolin
antilipidni lijekovi
butiriltiokolin
Wistar štakori
Zucker štakori
03 medical and health sciences
Plasma
0302 clinical medicine
Fenofibrate
Internal medicine
medicine
Animals
Rats, Wistar
Saline
Butyrylcholinesterase
Hypolipidemic Agents
biology
Biotechnology in Biomedicine (natural science, biomedicine and healthcare, bioethics area
Chemistry
Anticholesteremic Agents
Public Health, Environmental and Occupational Health
Brain
Basic Medical Sciences
Butyrylcholinesterase activity
Enzyme assay
Rats
030104 developmental biology
Endocrinology
Liver
biology.protein
Cholinergic
030217 neurology & neurosurgery
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 18486312 and 00041254
- Volume :
- 70
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Arhiv za higijenu rada i toksikologiju
- Accession number :
- edsair.doi.dedup.....a17b6937fd3a20e084eec9775b9fd391